BOA1

Featured post

#Analysis of recent #scientific #information on #avian #influenza A(#H7N9) virus - 10 February 2017 (@WHO, edited)

  Title : #Analysis of recent #scientific #information on #avian #influenza A(#H7N9) virus - 10 February 2017. Subject : Avian Influenza, ...

28 Feb 2017

#Taiwan, the first imported #human case of #H7N9 #influenza died after nearly a month of treatment (Feb. 28 ‘17)

 

Title: Taiwan, the first imported human case of H7N9 influenza died after nearly a month of treatment.

Subject: Avian Influenza, H7N9 subtype, fatal human imported case in Taiwan. Drugs resistant strain.

Source: China News Agency, full page: (LINK). Article in Chinese, edited.

Code: [     ]

_____

First human case of the year died after twenty-seven days in hospital

___

At 20:00 on February 28, 2017 / China News Agency

A Taiwanese businessmen recently went to work in mainland China, diagnosed in early February infected H7N9 avian influenza, after 27 days after hospitalization, the condition continues to deteriorate and died due to multiple organ failure, the first Taiwanese to die of the illness.

Ministry of Health announced that in early February a 69-year-old Kaohsiung Taiwan businessmen, January 23 to work in Yangjiang City, Guangdong Province, China, due to fever, chills, 2 days after returning seek medical treatment, test the new influenza A Negative. On Jan. 29 developed fever, cough with sputum, respiratory difficulty and other symptoms, once again medical diagnosis of suspected pneumonia. On February 1 he was hospitalized again, and tested positive for H7N9, then admitted to the intensive care unit for Treatment.

Subsequently, the Department of Health found that H7N9 influenza virus developed a mutation toward the existing anti-influenz drug oseltamivir. At this point, doctors intended to use a new Japanese antiviral drug [favipiravir].

The Deputy Director of the Department of Vaccination, Dr Lo Yijun, said today that the patient was treated by an intensive care unit and an infectious disease specialist and continued to use antiviral drugs, respirators, leaf capsules, hemodialysis and other treatments. Despite the treatment he developed Multiple organ failure, and died on the evening of February 27.

Luo Yijun said that patients with age over 60 years of age, plus a history of hypertension, severe pneumonia, persistent hypoxemia, resistance to anti-influenza drugs, etc., these are known in the medical literature and H7N9 death associated with high risk factors , Even if the medical team to make every effort to treat, still unfortunately died.

Luo Yijun pointed out that the recent H7N9 cases in mainland China continued to increase, since October last year, 461 cases of H7N9 flu, the largest in Jiangsu Province, 128 cases, followed by Zhejiang Province, 79 cases, 52 cases in Guangdong Province, Anhui Province, 50 cases, Poultry, live poultry market exposure history, and another 1/3 no bird contact history, more than 50 years of age for the community, the mortality rate of nearly 40 percent.

The Department of Health has reiterated that the Chinese mainland is still at the peak of the H7N9 flu, both local businessmen and people planning to travel to the region should be vigilant, be sure to implement personal hygiene measures such as hand washing, to avoid contact with birds and Poultry market.

The Commission reminds that eating chickens, ducks, geese and eggs are cooked to avoid infection. If you have any symptoms such as fever and cough, you should take the initiative to inform the airline personnel and the airport port quarantine personnel. If you have any of the above symptoms, you should go to the ward for medical treatment. The relevant information can be found on the website of the UNDCP (http: /www.cdc.gov.tw), or call the Free Epidemic Prevention Line 1922 (or 0800-001922). 1060228

(Central News Agency)

-

Keywords: Taiwan; Avian Influenza; H7N9; Human; Antivirals; Drugs Resistance; Oseltamivir.

------